Post Tagged with: "Biomarkers"

Negative Biopsies with Rising Prostate-Specific Antigen. What to Do?

Negative Biopsies with Rising Prostate-Specific Antigen. What to Do?

Urology May 9, 2017 at 8:26 AM 0 comments

*Juan Gómez Rivas,1 Mario Alvarez-Maestro,1 Marcin Czarniecki,2 Stefan Czarniecki,3 Moises Rodriguez Socarras,4 Stacy Loeb5 1. Department of Urology, La Paz University Hospital, Madrid, Spain 2. Department of Radiology, Masovian Brodno Hospital, Warsaw, Poland 3. St. John Paul II Western Hospital, Grodzisk Mazowiecki, Poland 4. Department of Urology, Alvaro Cunqueiro UniversityRead More

Personalised Medicine with Companion Diagnostics: The Intercept of Medicines and Medical Devices in the Regulatory Landscape

Personalised Medicine with Companion Diagnostics: The Intercept of Medicines and Medical Devices in the Regulatory Landscape

Innovations January 10, 2017 at 8:26 AM 0 comments

*Amanda Craig Translational Neuroscience Facility and Department of Physiology, School of Medical Sciences, University of New South Wales, New South Wales, Australia *Correspondence to a.craig@unsw.edu.au Disclosure: Dr Amanda Craig is employed by the Therapeutic Goods Administration. The views and opinions expressed in this publication are those of the author and shouldRead More

In Search of Biomarkers in Eosinophilic Oesophagitis: We Are Not There Yet!

In Search of Biomarkers in Eosinophilic Oesophagitis: We Are Not There Yet!

Allergy & Immunology August 2, 2016 at 8:25 AM 0 comments

Neeti Bhardwaj,1 *Gisoo Ghaffari2 1. Department of Pediatrics, Division of Allergy and Immunology, Pennsylvania College of Medicine, Hershey, Pennsylvania, USA 2. Department of Medicine, Division of Pulmonary, Allergy, Critical Care Medicine, Pennsylvania College of Medicine, Hershey, Pennsylvania, USA *Correspondence to gghaffari@hmc.psu.edu. Disclosure: The authors have declared no conflicts of interest.Read More

Multiple Sclerosis: Where do we go from here?

Multiple Sclerosis: Where do we go from here?

Neurology July 12, 2016 at 8:25 AM 0 comments

*Marta Tejera-Alhambra,1 Lidia Fernández-Paredes,2 Clara de Andrés,3 Silvia Sánchez-Ramón2 1. Medical Department, Inmunotek, S.L., Madrid, Spain 2. Department of Clinical Immunology, Hospital Clínico San Carlos, Madrid, Spain 3. Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain *Correspondence to tejeramarta@hotmail.com Disclosure: The authors have declared no conflicts of interest.Read More

Utility of Exosomes in the Diagnosis and Treatment of Pancreatic Adenocarcinoma

Utility of Exosomes in the Diagnosis and Treatment of Pancreatic Adenocarcinoma

European Medical Journal, Oncology January 26, 2016 at 9:02 AM 0 comments

Leo I. Amodu, Asaph Levy, Crystal Kyaw, Darshan Padmanabhan, Alexandra Osman, Mukesh Tiwari, Jeffrey Nicastro, Gene Coppa, Ernesto Molmenti, *Horacio L. Rodriguez Rilo Center for Diseases of the Pancreas, Department of General Surgery, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York, USA *Correspondence to Hrilo@nshs.edu Disclosure: TheRead More

Update on Alzheimer’s Disease

Update on Alzheimer’s Disease

Neurology August 6, 2015 at 9:00 AM 0 comments

*Kurt A. Jellinger Institute of Clinical Neurobiology, Vienna, Austria *Correspondence to kurt.jellinger@univie.ac.at Disclosure: The author has declared no conflicts of interest. Received: 17.12.14 Accepted: 13.02.15 Citation: EMJ Neurol. 2015;3[1]:82-90. Abstract With the disproportionate growth of the elderly population, Alzheimer’s disease (AD), as the most common cause of dementia, has becomeRead More

Management of Refractory Lupus Nephritis

Management of Refractory Lupus Nephritis

Nephrology July 14, 2015 at 9:40 AM 0 comments

Antonis Fanouriakis,1,2 *George Bertsias1,2 1. Department of Rheumatology, Clinical Immunology, and Allergy, University Hospital of Heraklion, Heraklion, Crete, Greece 2. Institute of Molecular Biology and Biotechnology, Foundation for Research & Technology – Hellas (FORTH), Heraklion, Crete, Greece *Correspondence to gbert@med.uoc.gr Disclosure: The authors have declared no conflicts of interest. Received:Read More

Frequent Exacerbators in Chronic Obstructive Pulmonary Disease: From Research to Clinical Practice

Frequent Exacerbators in Chronic Obstructive Pulmonary Disease: From Research to Clinical Practice

Respiratory May 19, 2015 at 9:45 AM 0 comments

Richard Hewitt,1 *Patrick Mallia2 1. Imperial College Healthcare NHS Trust, London, UK 2. Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, UK *Correspondence to p.mallia@imperial.ac.uk Disclosure: The authors have declared no conflicts of interest. Received: 25.11.14 Accepted: 23.02.15 Citation: EMJ Respir. 2015;3[1]:29-36. Abstract Acute exacerbationsRead More

Event-Driven Studies and Serious Chronic Diseases: Addressing Placebo, Drug Efficacy, and Treatment Failure in Pulmonary Artery Hypertension

Event-Driven Studies and Serious Chronic Diseases: Addressing Placebo, Drug Efficacy, and Treatment Failure in Pulmonary Artery Hypertension

Respiratory October 24, 2014 at 9:55 AM 0 comments

Henning Gall,1 Paul Corris2 1. University of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands 2. Department of Respiratory Medicine, Institute of Transplantation and Institute of Cellular Medicine, Newcastle University, and the Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne,Read More

Brief Clinical Review: Non-Responding Pneumonia

Brief Clinical Review: Non-Responding Pneumonia

Respiratory October 24, 2014 at 9:18 AM 0 comments

Simon Finch, *James D. Chalmers Tayside Respiratory Research Group, University of Dundee and Ninewells Hospital and Medical School, Dundee, Scotland *Correspondence to jchalmers@dundee.ac.uk Disclosure: No potential conflict of interest. Received: 05.05.14 Accepted: 24.07.14 Citation: EMJ Respir. 2014;2:104-111. Abstract A slowly resolving or non-resolving pneumonia (NRP) is a common clinical dilemma,Read More